Provided by Tiger Trade Technology Pte. Ltd.

Vera Therapeutics, Inc.

35.28
+1.564.63%
Pre-market: 35.500.2200+0.62%05:16 EDT
Volume:2.49M
Turnover:86.87M
Market Cap:2.53B
PE:-5.98
High:35.57
Open:34.05
Low:34.00
Close:33.72
52wk High:56.05
52wk Low:21.15
Shares:71.71M
Float Shares:62.80M
Volume Ratio:1.65
T/O Rate:3.96%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-5.8984
EPS(LYR):-4.6644
ROE:-91.75%
ROA:-46.76%
PB:6.20
PE(LYR):-7.56

Loading ...

Vera Therapeutics (VERA) Gets a Buy from LifeSci Capital

TIPRANKS
·
May 08

Vera Therapeutics, Inc reports results for the quarter ended March 31 - Earnings Summary

Reuters
·
May 07

Vera Therapeutics Q1 EPS $(1.69) Misses $(1.34) Estimate

Benzinga Earnings
·
May 07

Vera Therapeutics Q1 net loss widens to $121.03 million

Reuters
·
May 07

BRIEF-Vera Therapeutics Q1 EPS USD -1.69 Vs. IBES Estimate USD -1.33

Reuters
·
May 07

Vera Therapeutics, Inc - U.S. Commercial Launch of Atacicept Expected Mid-2026, Pending Approval

THOMSON REUTERS
·
May 07

Vera Therapeutics, Inc - $596.8 Mln in Cash, Cash Equivalents, and Marketable Securities as of March 31, 2026

THOMSON REUTERS
·
May 07

Press Release: Vera Therapeutics Provides Business Update and Reports First Quarter 2026 Financial Results

Dow Jones
·
May 07

Vera Therapeutics to present at Bank of America Securities 2026 Health Care Conference

Reuters
·
May 04

Vera CEO Marshall Fordyce disposes of Vera Therapeutics shares worth $1,018,054

Reuters
·
Apr 16

BRIEF-Vera Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)

Reuters
·
Apr 11

Vera Therapeutics grants inducement awards to 89 hires, issuing 258,200 options and 131,925 RSUs

Reuters
·
Apr 11

Vera Therapeutics announces annual shareholder meeting

Reuters
·
Apr 10

Vera Therapeutics grants 56,850 stock options at $40.73; issues 42,403 RSUs under 2024 Inducement Plan

Reuters
·
Mar 28

Vera Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

GlobeNewswire
·
Mar 28

Vera Therapeutics appoints Jane Wright-Mitchell chief legal officer

Reuters
·
Mar 25

Analysts Conflicted on These Healthcare Names: Cochlear (OtherCHEOF), Universal Health (UHS) and Vera Therapeutics (VERA)

TIPRANKS
·
Mar 17

Assessing Vera Therapeutics (VERA) Valuation As Deerfield Ups Stake And FDA Priority Review Nears

Simply Wall St.
·
Mar 16

Vera Therapeutics Raised to Outperform From Peer Perform by Wolfe Research

Dow Jones
·
Mar 11

Vera Therapeutics upgraded to Outperform from Peer Perform at Wolfe Research

TIPRANKS
·
Mar 11